Skip to content
RushPR News – Lifestyle
Author:
MyOme, Inc
MyOme Strengthens Board with Appointment of Two Healthcare Leaders
April 21, 2026
MyOme Demonstrates Clinical Validity of Integrated Polygenic and Clinical Risk Prediction for Coronary Artery Disease
March 20, 2026
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
March 12, 2026